Search Results

Site Search

Leveraging Lessons from the Past - Insights

Sharing lessons learned from past process improvement and other projects conducted at Mayo Clinic.

T-cell lymphoma - Insights

We offer next-generation sequencing and comprehensive fluorescence in situ hybridization (FISH) panels, as well as extensive immunohistochemistry (IHC) offerings, to diagnose and monitor T-cell lymphoma.

Pan cancer - Insights

Learn about our comprehensive MayoComplete solid tumor panel, which analyzes 515 genes for mutations, rearrangements, and amplifications.

Lung Cancer NGS Panel - Mayo Clinic Laboratories

Our targeted lung cancer panel assesses for mutations in eight genes, and rearrangements in four genes, including those recommended by the National Comprehensive Cancer Network: EGFR, ROS1, BRAF, and ALK.

MayoComplete - Insights

Browse our menu of MayoComplete next-generation sequencing assays which are designed to identify a growing list of hematological cancers.

FISH testing - Insights

Find out how our streamlined approach to fluorescence in situ hybridization testing can simplify the ordering process and better meet patient needs.

Thrombotic microangiopathy (TMA) - Insights

View our comprehensive testing suite designed to confirm diagnosis and facilitate treatment of thrombotic microangiopathy.

Lipid assay improves cardiovascular risk prediction: Jeff Meeusen, Ph.D. - Insights

Jeff Meeusen, Ph.D., explains how Mayo Clinic Laboratories' new MI-Heart Ceramides assay helps guide the management of patients with mildly to moderately high cholesterol. The test measures levels of lipids beyond cholesterol that boost...

New Panels Help Find Cause of Rapidly Progressive Dementia: Gregg Day, M.D. - Insights

Rapidly progressive dementia (RPD) is an umbrella term covering many devasting conditions, including Creutzfeldt-Jakob disease (CJD). Gregory (Gregg) Day, M.D., explains how Mayo Clinic Laboratories' unique RPD evaluation and new CJD test...

Panel Detects Demyelinating Neuropathy Biomarkers: John Mills, Ph.D., and Divyanshu Dubey, M.B.B.S. - Insights

John Mills, Ph.D., and Divyanshu Dubey, M.B.B.S., explain how Mayo Clinic Laboratories' new test panel can distinguish among various potential causes of demyelinating neuropathies. Test results are important for managing these devastating...